52 related articles for article (PubMed ID: 31927783)
1. Defining the surgical management for non-colorectal liver metastases.
Luk Y; She WH; Tsang SHY; Dai WC; Chan ACY; Cheung TT; Lo CM
Langenbecks Arch Surg; 2023 Jan; 408(1):35. PubMed ID: 36648566
[TBL] [Abstract][Full Text] [Related]
2. Indications for conversion hepatectomy for initially unresectable colorectal cancer with liver metastasis.
Sugiyama M; Uehara H; Shin Y; Shiokawa K; Fujimoto Y; Mano Y; Komoda M; Nakashima Y; Sugimachi K; Yamamoto M; Morita M; Toh Y
Surg Today; 2022 Apr; 52(4):633-642. PubMed ID: 34762175
[TBL] [Abstract][Full Text] [Related]
3. Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis: A Retrospective Cohort Study.
Chen Y; Zhu D; Chen M; Xu Y; Ye Q; Wang X; Xu P; Feng Q; Ji M; Wei Y; Fan J; Xu J
Clin Colorectal Cancer; 2023 Dec; 22(4):464-473.e5. PubMed ID: 37730473
[TBL] [Abstract][Full Text] [Related]
4. Comparison of post-hepatectomy long-term survival outcome between non-colorectal non-neuroendocrine and colorectal liver metastases: A population-based propensity-score matching analysis.
Ng KKC; Lok HT; Lee KF; Cheung TT; Chia NH; Ng WK; Law CK; Cheung CY; Cheng KC; Cheung SYS; Lai PBS
Surgeon; 2024 Apr; 22(2):e100-e108. PubMed ID: 38081758
[TBL] [Abstract][Full Text] [Related]
5. Determining timing of hepatectomy for colorectal cancer with distant metastasis according to imaging-based tumor shrinkage ratio.
Sasaki Y; Osada S; Mori R; Imai H; Tanaka Y; Matsuhashi N; Okumura N; Nonaka K; Takahashi T; Yoshida K
Int J Med Sci; 2013; 10(9):1231-41. PubMed ID: 23935401
[TBL] [Abstract][Full Text] [Related]
6. Systemic treatment of liver metastases from colorectal cancer.
Stein A; Schmoll HJ
Ther Adv Med Oncol; 2013 May; 5(3):193-203. PubMed ID: 23634197
[TBL] [Abstract][Full Text] [Related]
7. Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trial.
Adam R; Badrudin D; Chiche L; Bucur P; Scatton O; Granger V; Ducreux M; Cillo U; Cauchy F; Lesurtel M; Mabrut JY; Verslype C; Coubeau L; Hardwigsen J; Boleslawski E; Muscari F; Jeddou H; Pezet D; Heyd B; Lucidi V; Geboes K; Lerut J; Majno P; Grimaldi L; Boukhedouni N; Piedvache C; Gelli M; Levi F; Lewin M
EClinicalMedicine; 2024 Jun; 72():102608. PubMed ID: 38721015
[TBL] [Abstract][Full Text] [Related]
8. Clinical Complete Response After Conversion Therapy for Unresectable Hepatocellular Carcinoma: Is Salvage Hepatectomy Necessary?
Wu JY; Wu JY; Liu DY; Li H; Zhuang SW; Li B; Zhou JY; Huang JY; Zhang ZB; Li SQ; Yan ML; Wang YD
J Hepatocell Carcinoma; 2023; 10():2161-2171. PubMed ID: 38076640
[TBL] [Abstract][Full Text] [Related]
9. New Insights into Macrophage Polarization and its Prognostic Role in Patients with Colorectal Cancer Liver Metastasis.
Khanduri I; Maki H; Verma A; Katkhuda R; Anandappa G; Pandurengan R; Zhang S; Mejia A; Tong Z; Soto LMS; Jadhav A; Wistuba II; Kopetz S; Parra ER; Vauthey JN; Maru DM
Res Sq; 2023 Oct; ():. PubMed ID: 37886575
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation in treatment of colorectal liver metastases.
Hagness M
Hepat Oncol; 2015 Apr; 2(2):181-190. PubMed ID: 30190997
[TBL] [Abstract][Full Text] [Related]
11. Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases.
Østrup O; Dagenborg VJ; Rødland EA; Skarpeteig V; Silwal-Pandit L; Grzyb K; Berstad AE; Fretland ÅA; Mælandsmo GM; Børresen-Dale AL; Ree AH; Edwin B; Nygaard V; Flatmark K
Oncotarget; 2017 Sep; 8(44):76290-76304. PubMed ID: 29100312
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis.
Takamizawa Y; Inoue M; Moritani K; Tsukamoto S; Esaki M; Shimada K; Kanemitsu Y
Langenbecks Arch Surg; 2022 Nov; 407(7):2893-2903. PubMed ID: 36068379
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
[TBL] [Abstract][Full Text] [Related]
14. Resection of colorectal liver metastases after second-line chemotherapy: is it worthwhile? A LiverMetSurvey analysis of 6415 patients.
Adam R; Yi B; Innominato PF; Barroso E; Laurent C; Giuliante F; Capussotti L; Lapointe R; Regimbeau JM; Lopez-Ben S; Isoniemi H; Hubert C; Lin JK; Gruenberger T; Elias D; Skipenko OG; Guglielmi A;
Eur J Cancer; 2017 Jun; 78():7-15. PubMed ID: 28407529
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases.
Lam VW; Laurence JM; Johnston E; Hollands MJ; Pleass HC; Richardson AJ
HPB (Oxford); 2013 Jul; 15(7):483-91. PubMed ID: 23750490
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases.
Lam VW; Spiro C; Laurence JM; Johnston E; Hollands MJ; Pleass HC; Richardson AJ
Ann Surg Oncol; 2012 Apr; 19(4):1292-301. PubMed ID: 21922338
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary approach of colorectal liver metastases.
Juez I; Rubio C; Figueras J
Clin Transl Oncol; 2011 Oct; 13(10):721-7. PubMed ID: 21975333
[TBL] [Abstract][Full Text] [Related]
18. Type of response to conversion chemotherapy strongly impacts survival after hepatectomy for initially unresectable colorectal liver metastases.
Zimmitti G; Panettieri E; Ardito F; Rosso E; Mele C; Nuzzo G; Giuliante F
ANZ J Surg; 2020 Apr; 90(4):558-563. PubMed ID: 31927783
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
